SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-012878
Filing Date
2020-07-09
Accepted
2020-07-09 06:02:25
Documents
6
Period of Report
2020-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 42716
2 ex10-1.htm EX-10.1 248981
3 ex10-2.htm EX-10.2 109183
4 ex10-3.htm EX-10.3 111445
5 ex10-4.htm EX-10.4 61032
6 ex99-1.htm EX-99.1 12893
  Complete submission text file 0001493152-20-012878.txt   587527
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 201019469
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences